Upgrade to SI Premium - Free Trial

Pre-Open Stock Movers 11/12: (ANGI) (NTES) (GALE) Higher; (DSCI) (DGLY) (FRPT) Lower (more...)

November 12, 2015 9:33 AM
Derma Sciences (NASDAQ: DSCI) 29.4% LOWER; announces the termination of its Phase 3 clinical trials with aclerastide (DSC127) for diabetic ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles